National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...
Lantern Pharma (NASDAQ:LTRN – Get Free Report) is expected to be announcing its earnings results before the market opens on ...
ARC101, a potential best-in-class T-cell engager that targets solid tumors expressing CLDN6, is being assessed in a ...
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Clinical Trials Arena on MSN22h
BioCity and MSD to evaluate cancer treatment combination in Phase I/II trialBioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with ...
TipRanks on MSN11h
Candel Therapeutics Reports Positive Clinical Trial ResultsCandel Therapeutics, Inc. ( ($CADL) ) has released its Q4 earnings. Here is a breakdown of the information Candel Therapeutics, Inc. presented to ...
Arizona State Retirement System grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 12.4% during the ...
During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...
The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close contact with someone who is infected vulnerable to developing COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback